找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Stereotactic Radiosurgery for Prostate Cancer; Michael J. Zelefsky Book 2019 Springer International Publishing AG, part of Springer Nature

[复制链接]
楼主: PED
发表于 2025-3-25 05:54:36 | 显示全部楼层
发表于 2025-3-25 07:48:41 | 显示全部楼层
Daniel Lam Cham Kee,Jérôme Doyen,Alexander T. Falk,Jean-Michel Hannoun-Leviat African Americans generally and older African Americans in particular face continued subjugation and economic difficulties due to racial group membership (Hughes and Hertel, 1990). Some suggest that the changes brought about over the past 30 years by civil rights have done little to alter the day
发表于 2025-3-25 12:45:01 | 显示全部楼层
发表于 2025-3-25 19:52:15 | 显示全部楼层
发表于 2025-3-25 20:19:25 | 显示全部楼层
发表于 2025-3-26 00:30:52 | 显示全部楼层
Optimizing Selection of Patients for Prostate SBRT: Overview of Toxicity and Efficacy in Low, Interbody of evidence supports the efficacy and safety of SBRT not only for low PCa, but also for intermediate risk disease. We also review some of the reports describing higher than anticipated toxicities, and provide likely explanations for these discrepancies. Potential contraindications to SBRT, such
发表于 2025-3-26 07:34:25 | 显示全部楼层
发表于 2025-3-26 12:28:10 | 显示全部楼层
Overview of Tumor Control Outcomes with Prostate SBRT for Low and Intermediate Risk Prostate Cancermodalities and difference in clinical outcomes has been shown for those receiving prostatectomy or radiotherapy; high-tier intermediate risk patients, on the other hand have better outcome with combination of EBRT and BT. There is emerging, albeit early evidence that hypofractionated radiotherapy re
发表于 2025-3-26 13:05:30 | 显示全部楼层
发表于 2025-3-26 20:00:24 | 显示全部楼层
Dose Escalation for Prostate Cancer Using Oligofractionated, Stereotactic Ablative Radiotherapy,for decades, the current form is more apt to avoid toxicity by using modern technological advances in imaging, dosimetry and radiation delivery. In addition to a high likelihood of durable biochemical control, this form of treatment is far more convenient for patients, and potentially reduces the ov
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-6 04:30
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表